August 24, 2014 | Israeli biotechnology company NeuroDerm raised $16 million in investments to continue working on its wearable treatment for Parkinson’s disease. The financing round was led by existing investors. The company is currently in the midst of a mid-stage study for its treatment for neurodegenerative disease, a belt pump that is worn around the waist and continuously administers Parkinson’s drugs for the most severe cases. The company and the testing of their Phase II treatment received a $1 million from the Michael J. Fox Foundation for Parkinson’s Research.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Clean Energy Firm Completes Solar Project In North, South Israel
October 15, 2024
Cannabis Therapy Firm: CBD Jab Reduces Pain In Arthritic Dogs
October 15, 2024
US Government Funding Development Of Israeli Ebola Treatment
October 14, 2024
Security Firm Wins Prison Service Contract For Electronic Monitoring
October 14, 2024
Facebook comments